S2 FEMORAL A/R NAIL S2 FEMORAL COMRESSION NAIL S2 TIBIAL NAIL S2 TIBIAL COMPRESSION NAIL

K113409 · Howmedica Osteonics Corp. · HSB · Feb 15, 2012 · Orthopedic

Device Facts

• Record ID: K113409
• Device Name: S2 FEMORAL A/R NAIL S2 FEMORAL COMRESSION NAIL S2 TIBIAL NAIL S2 TIBIAL COMPRESSION NAIL
• Applicant: Howmedica Osteonics Corp.
• Product Code: HSB · Orthopedic
• Decision Date: Feb 15, 2012
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3020
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

These devices are fracture fixation devices comprised of femoral and tibial nails and the related accessories such as locking screws, compression screws, end caps, condyle screws, and a condyle screw nut. The S2 tibial nail is intended to provide temporary stabilization of various types of fractures, malunions and nonunion of the tibia. The S2 femoral nail is intended to provide temporary stabilization of various types of fractures, malunions and nonunion of the femur.

Device Story

S2 Nail System comprises intramedullary nails and accessories (locking/compression screws, end caps, condyle screws/nuts) for temporary stabilization of long bone fractures. System includes targeter devices as accessories to facilitate nail insertion. Used in clinical settings by orthopedic surgeons via open or closed surgical techniques. Nails provide mechanical fixation for tibial and femoral fractures, malunions, nonunions, and pathologic conditions. Output is physical stabilization of bone segments. Benefits include restoration of alignment and support for bone healing.

Clinical Evidence

No clinical data. Evidence provided via human cadaveric lab and mechanical bench testing. Cadaveric testing confirmed successful implantation using targeter and components. Bench testing demonstrated modifications to nail adapter do not introduce worst-case performance scenarios.

Technological Characteristics

Intramedullary fixation rod system. Materials and design consistent with predicate S2 Nail System. Includes femoral and tibial nails, locking/compression screws, end caps, condyle screws/nuts, and targeter accessories. Mechanical fixation principle. No software or electronic components.

Indications for Use

Indicated for long bone fracture fixation in patients requiring stabilization of tibial or femoral fractures, including open/closed fractures, pseudoarthrosis, correction osteotomy, pathologic fractures, impending pathologic fractures, tumor resections, nonunion, malunion, supracondylar fractures (femoral), ipsilateral femur fractures, fractures proximal to total knee arthroplasty, and fractures distal to hip joint.

Regulatory Classification

Identification

An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures.

Predicate Devices

• S2 Nail System (K032579)
• T2® Recon Nail System (K102992)

Submission Summary (Full Text)

{0}------------------------------------------------

## FEB 1 5 2012

## 510(k) Summary of Safety and Effectiveness

| Proprietary Name: | S2 Nail System |
|--------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Common Name: | Intramedullary Fixation Rod |
| Classification Name and Reference: | Intramedullary Fixation Rod<br>21 CFR §888.3020 |
| Proposed Regulatory Class: | Class II |
| Product Codes: | 87HSB: Rod, Fixation, Intramedullary and Accessory |
| For Information Contact: | Juma Hoshino<br>Regulatory Affairs Associate<br>Howmedica Osteonics Corp.<br>325 Corporate Drive<br>Mahwah. NJ 07430<br>Phone: [phone]; Fax [phone] |
| Legally Marketed Devices to Which<br>Substantial Equivalence Is Claimed: | K032579 - S2 Nail System<br>K 102992 – T2® Recon Nail System |
| Date Prepared: | November 17, 2011 |

### Description

This Traditional 510(k) submission is being supplied to the US FDA to include targeter devices as accessories to the S2 Nail System that was cleared under K032579.

### Intended Use

These devices are fracture fixation devices comprised of femoral and tibial nails and the related accessories such as locking screws, compression screws, end caps, condyle screws, and a condyle screw nut. The S2 tibial nail is intended to provide temporary stabilization of various types of fractures, malunions and nonunion of the tibia. The S2 femoral nail is intended to provide temporary stabilization of various types of fractures, malunions and nonunion of the femur.

#### Indications

#### S2 Tibial Nail

The S2 Tibial Nail is intended to provide temporary stabilization of various types of fractures, malunions and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically and compression locked. The S2 Tibial Nail System is indicated for long bone fracture fixation, specifically tibial fracture fixation, which may include the following:

{1}------------------------------------------------

- Open and closed tibial fractures .
- . Pseudoarthrosis and correction osteotomy
- Pathologic fractures, impending pathologic fractures, and tumor resections .
- . Nonunion and malunion

#### S2 Femoral Nail

The S2 Femoral Nail is indicated for long bone fracture fixation, specifically femoral fracture fixation, which may include the following:

- . Open and closed femoral fractures
- Pseudoarthrosis and correction osteotomy .
- . Pathologic fractures, impending pathologic fractures and tumor resections
- Supracondylar fractures, including those with intra-articular extension .
- Ipsilateral femur fractures .
- Fractures proximal to a total knee arthroplasty ●
- Fractures distal to a hip joint .
- . Nonunions and malunions

#### Summary of Technologies

The proposed device is substantially equivalent in intended use, materials and performance characteristics to the predicate device. Inclusion of targeter devices as an accessory to the S2 Nail System does not alter the technology.

### Non-Clinical Testing

A human cadaveric lab and mechanical tests were conducted. For the human cadaveric lab, the S2 nails were implanted using the targeter and other relevant components without any complications, demonstrating that products are performing as intended. In addition, bench testing conducted showed that the modifications made to the existing nail adapter does not introduce worst case scenario for product performance.

### Clinical Testing

Clinical testing was not required for this submission.

### Conclusion

The S2 Nail System devices are substantially equivalent to the predicate devices identified in this premarket notification.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three stripes forming its body and wing. The eagle is positioned to the right of a circular text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES USA".

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Howmedica Osteonics Corp. % Ms. Juma Hoshino 325 Corporate Drive Mahwah, New Jersey 07430.

Re: K113409

Trade/Device Name: S2 Nail System Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary fixation rod Regulatory Class: Class II Product Code: HSB Dated: November 17, 2011 Received: November 18, 2011

FEB 15 2012

Dear Ms. Hoshino:

We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your Section 910(x) pressure is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encrosure) to regars) to regars and the Medical Device Americal Drug commerce prior to May 26, 1976, the encordance with the provisions of the Federal Food. Drug, devices that have been recuire approval of a premarket approval application (PMA).
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PM and Cosment Act (Act) that do not require approvince to the general controls provisions of the Act. The You may, therefore, market the devices, belyer to the more of registration, listing of general controls provisions of the fict labeling, and prohibitions against misbranding and devices, good manufacturing practice, not evaluate information related to contract liability adulteration. Please note: CDAT does not evaluate include ing must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (soc above) into time major regulations affecting your device can be may be subject to additional controls: "Entrally any of to 898. In addition, FDA may lound in the Oode of I ouch 11 concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA s issualled of a backers with other requirements of the Act
that FDA has made a determination that your device complies - You must that FDA has made a delerimiation that Jour as reserved by other Federal agencies. You must of any Federal statutes and regulations and limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical CFK Part 807), labeling (21 CFR 803); models and manufacturing practice requirements as set

{3}------------------------------------------------

Page 2 - Ms. Juma Hoshino

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic form in alle qualisms of trovisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please n you active you .fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the I ou may obtain other generational and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,
Mark M. Mellers

Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

#### Indications for Use

# 510(k) Number (if known): _ K1134096pg 1/1)

Device Name: S2 Nail System

#### S2 Tibial Nail

The S2 Tibial Nail is intended to provide temporary stabilization of various types of fractures, malunions and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically and compression locked. The S2 Tibial Nail System is indicated for long bone fracture fixation, specifically tibial fracture fixation, which may include the following:

- Open and closed tibial fractures .
- Pseudoarthrosis and correction osteotomy .
- Pathologic fractures, impending pathologic fractures, and tumor resections .
- Nonunion and malunion .

#### S2 Femoral Nail

The S2 Femoral Nail is indicated for long bone fracture fixation, specifically femoral fracture fixation, which may include the following:

- . Open and closed femoral fractures
- Pseudoarthrosis and correction osteotomy .
- Pathologic fractures, impending pathologic fractures and tumor resections .
- Supracondylar fractures, including those with intra-articular extension ●
- Ipsilateral femur fractures ●
- Fractures proximal to a total knee arthroplasty .
- Fractures distal to a hip joint .
- Nonunions and malunions .

Over-The-Counter Use Prescription Use X AND/OR (21 CFR 807 Subpart C) (Part 21 CFR 801 Subpart D) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 1 of 1

Office of Device Evaluation (ODE)

***_*****_**, and I'm sorry, I can't do that.

(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices

510(k) Number K113409